Joost C. M. Meijers

发表

Procoagulant protein levels are differentially increased during human endotoxemia

T. van der Poll, P. Reitsma, J. Meijers, 2003, Journal of thrombosis and haemostasis : JTH.

Anticoagulant and anti‐inflammatory effects after peritoneal lavage with antithrombin in experimental polymicrobial peritonitis

M. Boermeester, T. V. van Gulik, J. Meijers, 2006, Journal of thrombosis and haemostasis : JTH.

Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416.

J. Berkhof, V. V. van Hinsbergh, M. Levi, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The lectin-like domain of thrombomodulin hampers host defense in pneumococcal pneumonia

V. Poll, M. Schouten, J. D. D. Boer, 2012 .

Analysis of Coagulation Cascade and Endothelial Cell Activation During Inhibition of Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Pathway in Cancer Patients

V. V. van Hinsbergh, M. Levi, P. Kostense, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.

P. D. de Groot, M. Mörgelin, R. Derksen, 2010, Blood.

β2‐Glycoprotein I is incorrectly named apolipoprotein H

P. D. de Groot, J. Marquart, J. Meijers, 2009, Journal of thrombosis and haemostasis : JTH.

Structure‐function relationships in thrombin‐activatable fibrinolysis inhibitor

J. Meijers, T. Plug, Joost C. M. Meijers, 2016, Journal of thrombosis and haemostasis : JTH.

The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment

F. Rosendaal, J. F. van der Heijden, A. A. Garcia, 2006, Journal of thrombosis and haemostasis : JTH.

Thrombin‐activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis

F. Baas, T. Poll, M. Brouwer, 2015, Journal of thrombosis and haemostasis : JTH.

Role of isoleucine residues 182 and 183 in thrombin‐activatable fibrinolysis inhibitor

B. Bouma, S. Havik, J. Meijers, 2005, Journal of thrombosis and haemostasis : JTH.

De-escalation of antimicrobial therapy in Gram-negative sepsis: easier said than done?

P. Tuinman, J. Hofstra, N. Juffermans, 2011, Critical Care.

Effects of Second and Third Generation Oral Contraceptives and their Respective Progestagens on the Coagulation System in the Absence or Presence of the Factor V Leiden Mutation

A. Algra, D. Grobbee, D. Grobbee, 2002, Thrombosis and Haemostasis.

Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients

T. Renné, B. Bouma, A. Squizzato, 2011, Journal of thrombosis and haemostasis : JTH.

Antiphospholipid syndrome

P. D. de Groot, R. Urbanus, J. Meijers, 2010, Hämostaseologie.

Factor XI promotes hemostasis in factor IX‐deficient mice

D. Monroe, J. Meijers, B. Mohammed, 2018, Journal of thrombosis and haemostasis : JTH.

C4b-binding protein protects coagulation factor Va from inactivation by activated protein C.

J. Rosing, J. Meijers, B. Bouma, 2000, Biochemistry.

Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen

R. Urbanus, J. Marquart, J. Meijers, 2022, Journal of thrombosis and haemostasis : JTH.